Proteomics

Dataset Information

0

Comparative Proteomics of Calcitriol-treated high- and no-responding Glioma stem-like cells


ABSTRACT: Glioblastoma is the most common primary brain cancer and is associated with poor survival and high rates of recurrent diseases. The median survival using standard radio-chemotherapy is 15 months and the 5-year survival rate is below 5%. It is hypothesized that treatment resistance, diffuse infiltration of the brain and disease recurrence is, at least in part, due to cancer cells that can obtain a transient, stem-like phenotype. These so-called glioma stem-like cells (GSCs) display pluripotency, express marker proteins associated with stem-cells and can replenish the tumor after treatment. Recently, we have shown that the hormonally active form of vitamin D3, calcitriol (1α,25(OH)2-vitamin D3), is active in a subset of GSCs and reduces traits of stemness. Here, we have employed a set of 8 GSCs that do not respond to calcitriol-treatment (No-responder) and the 8 strongest responders to calcitriol (High-responder) and compared to proteomes after treatment with 50 nM calcitriol for 48h.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Christian Münch  

LAB HEAD: Christian Münch

PROVIDER: PXD041634 | Pride | 2023-11-04

REPOSITORIES: Pride

Dataset's files

Source:

Similar Datasets

2021-07-19 | PXD026789 | Pride
2009-12-29 | GSE19670 | GEO
2022-01-01 | E-MTAB-9607 | biostudies-arrayexpress
2020-09-28 | PXD019876 | Pride
2022-09-09 | GSE212728 | GEO
2016-08-27 | GSE86098 | GEO
2021-05-19 | GSE157939 | GEO
2018-02-16 | GSE86406 | GEO
| EGAS00001007346 | EGA
2016-09-07 | GSE86493 | GEO